Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03693300
Title A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU

Facility Status City State Zip Country Details
Research Site Gainesville Georgia 30501 United States Details
Research Site Knoxville Tennessee 37920 United States Details
Research Site Creteil 94010 France Details
Research Site Paris Cedex 05 75248 France Details
Research Site Saint Priest en Jarez 42270 France Details
Research Site Toulouse Cedex 9 31400 France Details
Research Site Gauting 82131 Germany Details
Research Site Großhansdorf 22927 Germany Details
Research Site Hamm 59063 Germany Details
Research Site Hannover 30459 Germany Details
Research Site Heidelberg 69126 Germany Details
Research Site Avellino 83100 Italy Details
Research Site Meldola 47014 Italy Details
Research Site Milano 20133 Italy Details
Research Site Monza 20900 Italy Details
Research Site Parma 43126 Italy Details
Research Site Roma 00152 Italy Details
Research Site Barcelona 08907 Spain Details
Research Site Guadalajara 19002 Spain Details
Research Site Madrid 28041 Spain Details
Research Site Sevilla 41013 Spain Details
Research Site Valencia 46015 Spain Details
Research Site Leeds LS9 7TF United Kingdom Details
Research Site Manchester M20 4BX United Kingdom Details
Research Site Middlesbrough TS4 3BW United Kingdom Details
Research Site Nottingham NG5 1PB United Kingdom Details
Research Site Sheffield S10 2SJ United Kingdom Details
Research Site Stoke on Trent ST4 6QG United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field